Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Zenz

Showing results (111-120 of 183) with videos related to

Pageof 19
Sort By:
Signal Transduction and Targeted Therapy|January 4, 2026
Immunoglobulin heavy-chain status and stromal interactions shape ferroptosis sensitivity in chronic lymphocytic leukemiaMartin Böttcher, Lea Reemts, Paul J Hengeveld, et al.
Journal of Medicinal Chemistry|January 31, 2015
Improved synthesis of N-benzylaminoferrocene-based prodrugs and evaluation of their toxicity and antileukemic activitySteffen Daum, Vasiliy F Chekhun, Igor N Todor, et al.
The Journal of Clinical Investigation|October 21, 2014
BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemiaNiuscha Yaktapour, Frank Meiss, Justin Mastroianni, et al.
Blood|April 15, 2018
TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphomaAlexander Jethwa, Mikołaj Słabicki, Jennifer Hüllein, et al.
Leukemia & Lymphoma|April 26, 2013
Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemiaG Doreen te Raa, Jitka Malcikova, Sarka Pospisilova, et al.
Cancer Discovery|December 21, 2013
Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemiaChristopher C Oakes, Rainer Claus, Lei Gu, et al.
Leukemia|August 7, 2021
CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressivenessRichard Lewis, H Carlo Maurer, Nikita Singh, et al.
Blood|February 26, 2013
TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trialPeter Dreger, Andrea Schnaiter, Thorsten Zenz, et al.
Cell Reports|October 4, 2023
Negative feedback regulation of MAPK signaling is an important driver of chronic lymphocytic leukemia progressionVeronika Ecker, Lisa Brandmeier, Martina Stumpf, et al.
British Journal of Haematology|July 1, 2014
Assessment of TP53 functionality in chronic lymphocytic leukaemia by different assays; an ERIC-wide approachG Doreen Te Raa, Jitka Malčiková, Marek Mraz, et al.
Pageof 19

Showing results (111-120 of 183) with videos related to

Sort By:
Pageof 19
Signal Transduction and Targeted Therapy|January 4, 2026
Immunoglobulin heavy-chain status and stromal interactions shape ferroptosis sensitivity in chronic lymphocytic leukemiaMartin Böttcher, Lea Reemts, Paul J Hengeveld, et al.
Journal of Medicinal Chemistry|January 31, 2015
Improved synthesis of N-benzylaminoferrocene-based prodrugs and evaluation of their toxicity and antileukemic activitySteffen Daum, Vasiliy F Chekhun, Igor N Todor, et al.
The Journal of Clinical Investigation|October 21, 2014
BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemiaNiuscha Yaktapour, Frank Meiss, Justin Mastroianni, et al.
Blood|April 15, 2018
TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphomaAlexander Jethwa, Mikołaj Słabicki, Jennifer Hüllein, et al.
Leukemia & Lymphoma|April 26, 2013
Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemiaG Doreen te Raa, Jitka Malcikova, Sarka Pospisilova, et al.
Cancer Discovery|December 21, 2013
Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemiaChristopher C Oakes, Rainer Claus, Lei Gu, et al.
Leukemia|August 7, 2021
CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressivenessRichard Lewis, H Carlo Maurer, Nikita Singh, et al.
Blood|February 26, 2013
TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trialPeter Dreger, Andrea Schnaiter, Thorsten Zenz, et al.
Cell Reports|October 4, 2023
Negative feedback regulation of MAPK signaling is an important driver of chronic lymphocytic leukemia progressionVeronika Ecker, Lisa Brandmeier, Martina Stumpf, et al.
British Journal of Haematology|July 1, 2014
Assessment of TP53 functionality in chronic lymphocytic leukaemia by different assays; an ERIC-wide approachG Doreen Te Raa, Jitka Malčiková, Marek Mraz, et al.
Pageof 19